ES539000A0 - Un procedimiento para preparar un derivado de una enzima fibronolitica - Google Patents

Un procedimiento para preparar un derivado de una enzima fibronolitica

Info

Publication number
ES539000A0
ES539000A0 ES539000A ES539000A ES539000A0 ES 539000 A0 ES539000 A0 ES 539000A0 ES 539000 A ES539000 A ES 539000A ES 539000 A ES539000 A ES 539000A ES 539000 A0 ES539000 A0 ES 539000A0
Authority
ES
Spain
Prior art keywords
fibronolytic
enzyme
derivative
preparing
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539000A
Other languages
English (en)
Other versions
ES8609468A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES8609468A1 publication Critical patent/ES8609468A1/es
Publication of ES539000A0 publication Critical patent/ES539000A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES539000A 1983-12-24 1984-12-21 Un procedimiento para preparar un derivado de una enzima fibronolitica Expired ES8609468A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838334499A GB8334499D0 (en) 1983-12-24 1983-12-24 Derivatives

Publications (2)

Publication Number Publication Date
ES8609468A1 ES8609468A1 (es) 1986-09-01
ES539000A0 true ES539000A0 (es) 1986-09-01

Family

ID=10553871

Family Applications (2)

Application Number Title Priority Date Filing Date
ES539000A Expired ES8609468A1 (es) 1983-12-24 1984-12-21 Un procedimiento para preparar un derivado de una enzima fibronolitica
ES546739A Expired ES8605476A1 (es) 1983-12-24 1985-09-05 Un procedimiento para preparar un derivado de acido benzoico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES546739A Expired ES8605476A1 (es) 1983-12-24 1985-09-05 Un procedimiento para preparar un derivado de acido benzoico.

Country Status (12)

Country Link
US (3) US4600580A (es)
EP (2) EP0155388B1 (es)
JP (1) JPH0829085B2 (es)
AU (1) AU580747B2 (es)
CA (1) CA1271718A (es)
DE (2) DE3484655D1 (es)
ES (2) ES8609468A1 (es)
GB (1) GB8334499D0 (es)
GR (1) GR82558B (es)
MX (1) MX7663E (es)
NZ (1) NZ210696A (es)
ZA (1) ZA849927B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650270A (en) * 1982-02-01 1997-07-22 Northeastern University Molecular analytical release tags and their use in chemical analysis
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
US4880776A (en) * 1983-12-24 1989-11-14 Beecham Group P.L.C. Plasmin A-chain urokinase B-chain hybrid protein
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
GB8707369D0 (en) * 1987-03-27 1987-04-29 Beecham Group Plc Enzyme derivatives
US5217705A (en) * 1987-09-25 1993-06-08 Neorx Corporation Method of diagnosing blood clots using fibrin-binding proteins
US5151359A (en) * 1988-05-19 1992-09-29 Mitsui Toatsu Chemicals Incorporated Method for producing of human tissue type plasminogen activator
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5183754A (en) * 1988-10-04 1993-02-02 Mitsui Toatsu Chemicals, Incorporated Method for production of human tissue type plasminogen activator
US5272076A (en) * 1991-06-13 1993-12-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders using an adduct of t-PA
US6608204B1 (en) * 1994-12-13 2003-08-19 Corvas International, Inc. Aromatic heterocyclic derivatives as enzyme inhibitors
CA2269335C (en) * 1996-10-21 2010-05-25 Quadrant Healthcare (Uk) Limited Platelet substitutes and conjugation methods suitable for their preparation
US6321909B1 (en) * 1997-02-13 2001-11-27 Sky High, Llc System for storing polyethylene glycol solutions
WO2004082640A2 (en) * 2003-03-19 2004-09-30 New Century Pharmaceuticals, Inc. Human serum albumin conjugates with therapeutic compounds
US7541159B2 (en) * 2004-04-14 2009-06-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Molecular-specific urokinase antibodies
US10878790B1 (en) 2020-03-13 2020-12-29 Aspire Precision Instruments, LLC Device and method for amplitude modulated optical pickup for a stringed instrument

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US428593A (en) * 1890-05-27 Sleigh
US4464468A (en) * 1968-03-29 1984-08-07 Agence Nationale De Valorisation De La Recherche (Anvar) Immobilization of active protein by cross-linking to inactive protein
GB1463513A (en) * 1974-08-13 1977-02-02 Beecham Group Ltd Enzymes
CS181417B1 (en) * 1975-03-27 1978-03-31 Miroslav Bleha Method for preparing insoluble biologically active compounds
DE2621974A1 (de) * 1976-05-18 1977-11-24 Max Planck Gesellschaft Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials
US4082612A (en) * 1976-09-24 1978-04-04 Michael Reese Research Foundation Plasminogen activator complex
US4134792A (en) * 1976-12-06 1979-01-16 Miles Laboratories, Inc. Specific binding assay with an enzyme modulator as a labeling substance
SE427505B (sv) * 1977-03-04 1983-04-11 Pharmacia Diagnostics Ab Reagens till anvendning vid immunkemiska bestemningsmetoder
SE430062B (sv) * 1977-03-04 1983-10-17 Pharmacia Fine Chemicals Ab Kopplings- eller tioleringsreagens
US4233401A (en) * 1977-07-14 1980-11-11 Syva Company Antienzyme homogeneous competitive binding assay
DE2862449D1 (en) * 1977-08-22 1984-11-22 Nat Res Dev Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
SE446184B (sv) * 1979-01-12 1986-08-18 Toyo Jozo Kk Polyfunktionell disulfidforening anvendbar som tverbindande medel
US4305926A (en) * 1979-09-13 1981-12-15 Johannes Everse Immobilization of Streptokinase
US4286964A (en) * 1979-10-12 1981-09-01 Seed Brian S Polyfunctional epoxides and halohydrins used as bridging groups to bind aromatic amine group-containing alcohols and thiols to hydroxyl bearing substrates
FR2470773B1 (es) * 1979-11-28 1983-01-28 Pasteur Institut
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
SE450834B (sv) * 1980-11-19 1987-08-03 Biocompat Inc Sett att binda ett protein till en berare innehallande hydroxylgrupper
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
US4429008B1 (en) * 1981-12-10 1995-05-16 Univ California Thiol reactive liposomes
DE3361610D1 (en) * 1982-04-07 1986-02-06 Beecham Group Plc Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them
US4536391A (en) * 1982-11-17 1985-08-20 Otsuka Pharmaceutical Co. Process for preparing urokinase complex
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4542225A (en) * 1984-08-29 1985-09-17 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound

Also Published As

Publication number Publication date
AU580747B2 (en) 1989-02-02
JPH0829085B2 (ja) 1996-03-27
ES8609468A1 (es) 1986-09-01
US4741903A (en) 1988-05-03
EP0283563A3 (en) 1988-11-23
CA1271718A (en) 1990-07-17
EP0283563A2 (en) 1988-09-28
DE3477469D1 (en) 1989-05-03
AU3707284A (en) 1985-07-04
NZ210696A (en) 1989-04-26
DE3484655D1 (de) 1991-07-04
US4730050A (en) 1988-03-08
EP0155388B1 (en) 1989-03-29
EP0155388A3 (en) 1986-12-10
EP0155388A2 (en) 1985-09-25
GB8334499D0 (en) 1984-02-01
ES8605476A1 (es) 1986-03-16
JPS60178864A (ja) 1985-09-12
US4600580A (en) 1986-07-15
ZA849927B (en) 1986-04-30
ES546739A0 (es) 1986-03-16
EP0283563B1 (en) 1991-05-29
GR82558B (en) 1985-04-23
MX7663E (es) 1990-06-19

Similar Documents

Publication Publication Date Title
ES539563A0 (es) Un procedimiento para preparar derivados de fenilamino-mer- captoimidazol
ES539000A0 (es) Un procedimiento para preparar un derivado de una enzima fibronolitica
ES535210A0 (es) Un procedimiento para producir una enzima de glucoamilasa
ES545408A0 (es) Procedimiento para preparar una succinimida modificada
ES548671A0 (es) Un procedimiento para la preparacion de un derivado de dihi-dropiridina
ES538190A0 (es) Un procedimiento para preparar derivados de pirimidina
ES536138A0 (es) Procedimiento para preparar derivados azolicos
ES531931A0 (es) Un procedimiento para preparar un derivado de octahidro-benzo (f) quinoleina
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES546061A0 (es) Un procedimiento para preparar un derivado de uridina
MX156049A (es) Un procedimiento para la preparacion de una n - piperazinilalcanolanilida
ES533673A0 (es) Procedimiento para la obtencion de un derivado de fenilsulfonilguanidina
ES552910A0 (es) Un procedimiento para preparar derivados de indol
ES543236A0 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
MX13291A (es) Un derivado de pirrol ortocondensado y procedimiento para su preparacion.
AR240819A1 (es) Procedimiento para preparar una benzoquinolicina
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES544640A0 (es) Un procedimiento para la preparacion de una cefalosporina
ES546914A0 (es) Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES546356A0 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
ES528985A0 (es) Un procedimiento para la preparacion de una b- lactama
ES537999A0 (es) Un procedimiento para preparar un derivado de rodanina
ES537098A0 (es) Un procedimiento para preparar derivados de tiadiazina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506